{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:11:21Z","timestamp":1786446681739,"version":"build-2736575974"},"reference-count":63,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A single blind, randomized, placebo-controlled, single-center phase I clinical trial of a CD8<jats:sup>+<\/jats:sup>T-cell peptide epitope vaccine against infectious mononucleosis was conducted with 14 HLA B*0801-positive, Epstein-Barr virus (EBV)-seronegative adults. The vaccine comprised the HLA B*0801-restricted peptide epitope FLRGRAYGL and tetanus toxoid formulated in a water-in-oil adjuvant, Montanide ISA 720. FLRGRAYGL-specific responses were detected in 8\/9 peptide-vaccine recipients and 0\/4 placebo vaccine recipients by gamma interferon enzyme-linked immunospot assay and\/or limiting-dilution analysis. The same T-cell receptor V\u03b2 CDR3 sequence that is found in FLRGRAYGL-specific T cells from most EBV-seropositive individuals could also be detected in the peripheral blood of vaccine recipients. The vaccine was well tolerated, with the main side effect being mild to moderate injection site reactions. After a 2- to 12-year follow-up, 1\/2 placebo vaccinees who acquired EBV developed infectious mononucleosis, whereas 4\/4 vaccinees who acquired EBV after completing peptide vaccination seroconverted asymptomatically. Single-epitope vaccination did not predispose individuals to disease, nor did it significantly influence development of a normal repertoire of EBV-specific CD8<jats:sup>+<\/jats:sup>T-cell responses following seroconversion.<\/jats:p>","DOI":"10.1128\/jvi.01409-07","type":"journal-article","created":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T01:53:55Z","timestamp":1195696435000},"page":"1448-1457","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":143,"title":["Phase I Trial of a CD8<sup>+<\/sup>T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis"],"prefix":"10.1128","volume":"82","author":[{"given":"Suzanne L.","family":"Elliott","sequence":"first","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Suhrbier","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Miles","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Pye","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy T.","family":"Le","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rosenstengel","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Allworth","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Royal Brisbane Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Burrows","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cox","sequence":"additional","affiliation":[{"name":"CSL Limited, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pye","sequence":"additional","affiliation":[{"name":"CSL Limited, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J.","family":"Moss","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandvi","family":"Bharadwaj","sequence":"additional","affiliation":[{"name":"Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.03257.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80340-4"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2335"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2588"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00085-8"},{"key":"e_1_3_2_7_2","first-page":"7","volume":"5","year":"1999","unstructured":"Black, C. A. 1999. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J.5:7.","journal-title":"Dermatol. Online J."},{"key":"e_1_3_2_8_2","first-page":"633","volume":"83","year":"2000","unstructured":"Brown, A. E., L. Markowitz, S. Nitayaphan, P. Morgan, S. Sukwit, S. Chinaworapong, S. Leelasupasri, and D. Birx. 2000. DTH responsiveness of HIV-infected Thai adults. J. Med. Assoc. Thai.83:633-639.","journal-title":"J. Med. Assoc. Thai."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-9-2489"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830220128"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.1.345"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270126"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.6.1703"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-906"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.9.1395"},{"key":"e_1_3_2_16_2","first-page":"CD004402","volume":"3","year":"2006","unstructured":"Candy, B., and M. Hotopf. 2006. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst. Rev.3:CD004402.","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.8.4184"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(06)95006-4"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3928\/0090-4481-19910401-10"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/505400"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00468-X"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.10.4717-4728.2006"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.07.001"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0587-8"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011692"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.4.2019"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3566"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320260024022"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.12.8858-8864.1996"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.18.10391"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.4049\/jimmunol.150.11.5154","volume":"150","year":"1993","unstructured":"Khanna, R., S. R. Burrows, A. Suhrbier, C. A. Jacob, H. Griffin, I. S. Misko, T. B. Sculley, M. Rowe, A. B. Rickinson, and D. J. Moss. 1993. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. J. Immunol.150:5154-5162.","journal-title":"J. Immunol."},{"key":"e_1_3_2_33_2","first-page":"239","volume":"32","year":"2005","unstructured":"Klatt, T., Q. Ouyang, T. Flad, I. Koetter, H. J. Buhring, H. Kalbacher, G. Pawelec, and C. A. Muller. 2005. Expansion of peripheral CD8+ CD28\u2212 T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis. J. Rheumatol.32:239-251.","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_34_2","first-page":"462","volume":"36","year":"1985","unstructured":"Kuhlwein, A., and A. Bleyl. 1985. Tetanus antitoxin levels and reactions following tetanus vaccination. Hautarzt36:462-464.","journal-title":"Hautarzt"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.12.7428-7435.1993"},{"key":"e_1_3_2_36_2","first-page":"6952","volume":"62","year":"2002","unstructured":"Lin, C. L., W. F. Lo, T. H. Lee, Y. Ren, S. L. Hwang, Y. F. Cheng, C. L. Chen, Y. S. Chang, S. P. Lee, A. B. Rickinson, and P. K. Tam. 2002. Immunization with Epstein-Barr virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res.62:6952-6958.","journal-title":"Cancer Res."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200107)31:7<1989::AID-IMMU1989>3.0.CO;2-M"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910310609"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60864-7"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7156.423"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.008"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.1.72"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511571200"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1968.171"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.405"},{"key":"e_1_3_2_46_2","first-page":"11","volume":"108","year":"2006","unstructured":"Sauce, D., M. Larsen, S. J. Curnow, A. M. Leese, P. A. Moss, A. D. Hislop, M. Salmon, and A. B. Rickinson. 2006. EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood108:11-18.","journal-title":"Blood"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00175-9"},{"key":"e_1_3_2_48_2","first-page":"2942","volume":"108","year":"2006","unstructured":"Savoldo, B., J. A. Goss, M. M. Hammer, L. Zhang, T. Lopez, A. P. Gee, Y. F. Lin, R. E. Quiros-Tejeira, P. Reinke, S. Schubert, S. Gottschalk, M. J. Finegold, M. K. Brenner, C. M. Rooney, and H. E. Heslop. 2006. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood108:2942-2949.","journal-title":"Blood"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.2.1306-1309.1995"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000058745.02123.6F"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200002)30:2<671::AID-IMMU671>3.0.CO;2-H"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.11.1745"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.5.1815"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3739"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1997.63"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.1.2.207"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(84)90029-1"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2006.01936.x"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.162.3.1827","volume":"162","year":"1999","unstructured":"Tan, L. C., N. Gudgeon, N. E. Annels, P. Hansasuta, C. A. O'Callaghan, S. Rowland-Jones, A. J. McMichael, A. B. Rickinson, and M. F. Callan. 1999. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol.162:1827-1835.","journal-title":"J. Immunol."},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.5.1873-1874.2006"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.13.5845"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.15.7855"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00111-6"},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.4049\/jimmunol.162.12.7080","volume":"162","year":"1999","unstructured":"Wills, M. R., A. J. Carmichael, M. P. Weekes, K. Mynard, G. Okecha, R. Hicks, and J. G. Sissons. 1999. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J. Immunol.162:7080-7087.","journal-title":"J. Immunol."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01409-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01409-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T21:54:50Z","timestamp":1684101290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01409-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1128\/JVI.01409-07"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01409-07","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"2007-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-10-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}